Denmark· DK-28107080723
WELIREG
A belzutifan product containing belzutifan, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Belzutifan is registered in 14 of 19 countries.
Countries holding a registration under ATC L01XX74 (belzutifan), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Belzutifan · ATC L01XX74
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of belzutifan costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Belzutifan · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- FR France$0.54
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Belzutifan
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- L01XX74
- ATC class
- Belzutifan
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107080723
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01XX74
Belzutifan, as other registers publish it.
- PolandWeliregMerck Sharp & Dohme B.V.
- IcelandWeliregMerck Sharp & Dohme B.V.*
- CzechiaWELIREGMerck Sharp & Dohme B.V., Haarlem
- United StatesWELIREGMerck Sharp & Dohme LLC
- United StatesWELIREGMerck Sharp & Dohme LLC
- FinlandWELIREGMerck Sharp & Dohme B.V.
- CanadaWELIREGMERCK CANADA INC
- BelgiumWelireg 40 mgMerck Sharp & Dohme
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a03836e8-bbe0-4c4c-9e15-95618be03c56 GET /v1/drugs/a03836e8-bbe0-4c4c-9e15-95618be03c56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "40 mg",
"auth_role": "MOD",
"dk_drugid": "28107080723",
"substance": "Belzutifan",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45700"
}See everything about belzutifan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.